Drug Development Pipeline
Dirocaftor (PTI-808)
Status
Phase TwoTherapeutic Approach
Restore CFTR Function
Dirocaftor is a type of CFTR modulator called a potentiator. Potentiators help facilitate the opening of the chloride channel on the cell surface to allow chloride and sodium (salt) to move in and out of the cell.
Status
Phase 2 studies have been conducted to test the safety and effectiveness of dirocaftor in combination with two other CFTR modulators, posenacaftor (PTI-801) and nesolicaftor (PTI-428).
Sponsor
This program is sponsored by Proteostasis Therapeutics. It is being conducted through the Therapeutics Development Network.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More